MedPAC examines Medicare quality measurement, drug spending
At meetings this week, the Medicare Payment Advisory Commission discussed a wide range of quality-related topics, including measures for long-stay nursing facility residents, behavioral health care and the Medicare program, and reforming quality measurement implications for premium support. Commissioners also examined six proposals MedPAC staff believe have the potential to slow the rate of growth of pharmaceutical spending by Medicare. These options seek to increase price competition, address Part B drug price growth and improve the current payment formula and data. Commissioners also received a status report on Medicare Accountable Care Organizations. The commission will meet again in November.
Related News Articles
Headline
The Department of Health and Human Services June 26 announced new efforts to improve the Trusted Exchange Framework and Common Agreement. TEFCA is a common set…
Headline
Emergency department visits for suspected suicide attempts from 2021-2025 were highest among adolescents age 12-17 at 24.8%, according to a report released…
Headline
A blog by Noah Isserman, AHA director of health insurance and coverage policy, explains why a recent analysis by the Medicare Payment Advisory Commission…
Headline
The inaugural Hospital Capacity Management Leadership Forum, tailored to hospital and health system leaders responsible for hospital flow, will be held July 11…
Blog
Medicare Advantage now covers more than half of eligible Medicare beneficiaries, making its impact on hospitals, health systems and patients impossible to…
Perspective
Every day, hospitals and health systems are finding new and better ways to care for the people and communities they serve.You can see it in predictive…